Fred Locke, MD, Moffitt Cancer Center, explains why this hematologic cancer is such an attractive target for chimeric antigen ...

A study on the long-term safety of CAR T-cell therapy for B-cell lymphoma patients reveals a favourable safety profile with ...

During a Case-Based Roundtable® event, Natalie Galanina, MD, reviewed how outcomes have changed in patients with primary ...

Los Angeles students heading back to class after President's Day will encounter a new mandate: a district-wide cell phone ban that officially takes effect on Tuesday. As approved last June by the ...

Explore CAR-T responses and the challenges of durability in cancer treatment with innovative NKTR-255 interleukin-15 therapy.